| Website | safeguard.com |
| Phone | 610-293-0600 |
| Employees |
Safeguard Scientifics, Inc. (NYSE: SFE), a holding company, builds value in growth-stage technology and life sciences businesses by providing capital, as well as a range of strategic, operational and management resources. Our expertise and leadership help accelerate growth, build long-term value and enable business transformation for each of our partner companies. Through more than 50 years of service, Safeguard has helped build great companies that become market leaders. Safeguard specializes in:
* Growth Buyout Financings
* Growth Equity Financings
* Early-Stage Financings
| Company | Date | Round | Size | Participants |
| Molecular Biometrics | 1/10 | Series B | $12.5M | 3 |
| Quinnova Pharmaceuticals | 11/09 | Series B | $17.4M | 3 |
| MediaMath | 8/09 | Unattributed | $10M | 3 |
| OfferWire | 6/09 | Series C | $3.5M | 2 |
| OfferWire | 6/09 | Series C | $3.5M | 2 |
| Bridgevine | 6/09 | Series C | $3.5M | 2 |
| Avid Radiopharmaceuticals | 5/09 | Series D | $34.5M | 7 |
| Garnet Biotherapeutics | 2/09 | Series A | $10.4M | 3 |
| Swaptree | 9/08 | Series C | $3.3M | 1 |
| Alverix | 2/08 | Series A | $7.7M | 2 |
| Bridgevine | 8/07 | Series B | $7.1M | 1 |
| Avid Radiopharmaceuticals | 5/07 | Series C | $26M | 6 |